Biopharm was established in 1991 as the Algerian pharmaceuticals sector was being privatised. Today it is the leading indigenous pharmaceuticals company in Algeria with an estimated 12% share of the Algerian pharmaceuticals market. Core activities consist of import, distribution, wholesale and production of pharmaceutical products.

Biopharm’s leading market position stems from its vast product offering as it distributes over 500 prescription and over-the-counter products. Main suppliers include Boehringer, AstraZeneca, Novartis, Bayer, Abbott, Cipla, Schering Plough, Eli-Lilly, Pierre Fabre, Merck Sharpe Dome and Sanofi Aventis.